These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 28219831)

  • 1. Expression and characterization of the major capsid protein derived from a GII.6 norovirus strain isolated in China.
    Huo Y; Zheng L; Chen X; Ge L; Wang Y
    Microb Pathog; 2017 Apr; 105():131-137. PubMed ID: 28219831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of virus-like particles derived from a GII.3 norovirus strain distantly related with current dominating strains.
    Huo Y; Chen X; Zheng L; Huo J; Zhang S; Wang M; Wang Y
    Virus Genes; 2016 Oct; 52(5):613-9. PubMed ID: 27234312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric GII.3/GII.6 norovirus capsid (VP1) proteins: characterization by electron microscopy, trypsin sensitivity and binding to histo-blood group antigens.
    Ma S; Zheng L; Liu J; Wang W; Ma J; Cheng X; Ge L; Wang M; Huo Y; Shen S
    Arch Virol; 2018 Dec; 163(12):3265-3273. PubMed ID: 30143876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic and biological characterizations of a GI.3 norovirus.
    Zheng L; Zhang H; Ma J; Liu J; Ma S; Wang M; Huo Y
    Infect Genet Evol; 2020 Nov; 85():104554. PubMed ID: 32927119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linear epitope binding antibodies against GII.3 Norovirus exhibit no histo-blood group antigens (HBGAs) blocking effects.
    Ma S; Zhang F; Zheng L; Liu J; Ma J; Chen X; Yang Z; Wang W; Li L; Wang M; Huo Y
    Virus Genes; 2019 Jun; 55(3):280-289. PubMed ID: 30725444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic cleavage promotes disassembly of GII.3 norovirus virus like particles and its binding to salivary histo-blood group antigens.
    Huo Y; Wang W; Zheng L; Chen X; Shen S; Wang M
    Virus Res; 2017 Aug; 240():18-24. PubMed ID: 28754559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and immunological characterization of norovirus major capsid proteins from three different genotypes.
    Huo Y; Wan X; Ling T; Shen S
    Microb Pathog; 2016 Jan; 90():78-83. PubMed ID: 26616166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of a major capsid protein derived from a documented GII.6 norovirus strain.
    Zheng L; Wang W; Liu J; Huo Y; Qin C; Wang M; Shen S
    Arch Virol; 2017 Dec; 162(12):3863-3868. PubMed ID: 28866835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and biological characterization of a pandemic norovirus variant GII.4 Sydney 2012.
    Ge L; Chen X; Liu J; Zheng L; Chen C; Luo S; Guo P; Kong J; Song Y; Huo Y
    Virus Genes; 2020 Apr; 56(2):174-181. PubMed ID: 31912284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and immunological characterization of major capsid protein VP1 from distinct GII.2 norovirus clusters.
    Ma J; Liu J; Huo Y
    Sci Rep; 2024 Sep; 14(1):21035. PubMed ID: 39251865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete nucleotide sequence analysis of the norovirus GII.17: A newly emerging and dominant variant in China, 2015.
    Wang HB; Wang Q; Zhao JH; Tu CN; Mo QH; Lin JC; Yang Z
    Infect Genet Evol; 2016 Mar; 38():47-53. PubMed ID: 26687061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome characterization of a GII.6 norovirus strain identified in China.
    Xue L; Wu Q; Kou X; Cai W; Zhang J; Guo W
    Infect Genet Evol; 2015 Apr; 31():110-7. PubMed ID: 25660038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance and genotypes of circulating noroviruses in northern Taiwan, 2006-2011.
    Tsai CN; Lin CY; Lin CW; Shih KC; Chiu CH; Chen SY
    J Med Virol; 2014 Feb; 86(2):335-46. PubMed ID: 24009100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GII.6 norovirus major capsid protein VP1 derived from distinct clusters induce cross-blocking effects.
    Ma J; Liu J; Fu C; Huo Y
    Infect Genet Evol; 2024 Aug; 122():105617. PubMed ID: 38857640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norovirus GII.17 Virus-Like Particles Bind to Different Histo-Blood Group Antigens and Cross-React with Genogroup II-Specific Mouse Sera.
    Malm M; Tamminen K; Vesikari T; Blazevic V
    Viral Immunol; 2018 Dec; 31(10):649-657. PubMed ID: 30431404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Sera Collected between 1979 and 2010 Possess Blocking-Antibody Titers to Pandemic GII.4 Noroviruses Isolated over Three Decades.
    Sharma S; Carlsson B; Czakó R; Vene S; Haglund M; Ludvigsson J; Larson G; Hammarström L; Sosnovtsev SV; Atmar RL; Green KY; Estes MK; Svensson L
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28468886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.
    Mahar JE; Donker NC; Bok K; Talbo GH; Green KY; Kirkwood CD
    J Virol; 2014 Feb; 88(4):1942-52. PubMed ID: 24284328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analyses of norovirus GII.4 variants in Finnish children from 1998 to 2013.
    Huhti L; Blazevic V; Puustinen L; Hemming M; Salminen M; Vesikari T
    Infect Genet Evol; 2014 Aug; 26():65-71. PubMed ID: 24837668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor profile and immunogenicity of the non-epidemic norovirus GII.8 variant.
    Gao J; Xue L; Liang Y; Wang L; He F; Meng L; Cai W; Zhang J; Wang J; Ye Q; Wu S; Gu Q; Wu Q
    Virus Res; 2021 Dec; 306():198603. PubMed ID: 34662679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.